These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37134196)

  • 1. Immunosuppressant adherence in adult outpatient hematopoietic cell transplant recipients.
    McCune JS; Armenian SH; Nakamura R; Shan H; Kanakry CG; Mielcarek M; Gao W; Mager DE
    J Oncol Pharm Pract; 2024 Mar; 30(2):322-331. PubMed ID: 37134196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation Patients.
    Ice LL; Bartoo GT; McCullough KB; Wolf RC; Dierkhising RA; Mara KC; Jowsey-Gregoire SG; Damlaj M; Litzow MR; Merten JA
    Biol Blood Marrow Transplant; 2020 Sep; 26(9):1627-1634. PubMed ID: 32505809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions for increasing immunosuppressant medication adherence in solid organ transplant recipients.
    Mellon L; Doyle F; Hickey A; Ward KD; de Freitas DG; McCormick PA; O'Connell O; Conlon P
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012854. PubMed ID: 36094829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Once- Versus Twice-Daily Tacrolimus Dosing on Medication Adherence in Stable Renal Transplant Recipients: A Canadian Single-Center Randomized Controlled Trial.
    Paterson TSE; Demian M; Shapiro RJ; Loken Thornton W
    Can J Kidney Health Dis; 2019; 6():2054358119867993. PubMed ID: 31452902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the performance of a prior tacrolimus population pharmacokinetic kidney transplant model among adult allogeneic hematopoietic stem cell transplant patients.
    Zhu J; Campagne O; Torrice CD; Flynn G; Miller JA; Patel T; Suzuki O; Ptachcinski JR; Armistead PM; Wiltshire T; Mager DE; Weiner DL; Crona DJ
    Clin Transl Sci; 2021 May; 14(3):908-918. PubMed ID: 33502111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors that determine self-reported immunosuppressant adherence in kidney transplant recipients: a correlational study.
    Weng LC; Yang YC; Huang HL; Chiang YJ; Tsai YH
    J Adv Nurs; 2017 Jan; 73(1):228-239. PubMed ID: 27532342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mobile medication manager application to improve adherence with immunosuppressive therapy in renal transplant recipients: A randomized controlled trial.
    Han A; Min SI; Ahn S; Min SK; Hong HJ; Han N; Kim YS; Ahn C; Ha J
    PLoS One; 2019; 14(11):e0224595. PubMed ID: 31689320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.
    Sabry W; Le Blanc R; Labbé AC; Sauvageau G; Couban S; Kiss T; Busque L; Cohen S; Lachance S; Roy DC; Roy J
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):919-29. PubMed ID: 19589481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pilot Study of Continuous Infusion of Mycophenolate Mofetil for Prophylaxis of Graft-versus-Host-Disease in Pediatric Patients.
    Windreich RM; Goyal RK; Joshi R; Kenkre TS; Howrie D; Venkataramanan R
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):682-689. PubMed ID: 26740371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pilot Randomized Controlled Trial to Promote Immunosuppressant Adherence in Adult Kidney Transplant Recipients.
    Cukor D; Ver Halen N; Pencille M; Tedla F; Salifu M
    Nephron; 2017; 135(1):6-14. PubMed ID: 28049201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rurality and other factors associated with adherence to immunosuppressant medications in community-dwelling solid-organ transplant recipients.
    Sankaranarayanan J; Collier D; Furasek A; Reardon T; Smith LM; McCartan M; Langnas AN
    Res Social Adm Pharm; 2012; 8(3):228-39. PubMed ID: 21856247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Describing Predictors Of Regimen Nonadherence Among Kidney Recipients Using Multiple Measures.
    Balakrishnan A; Bailey S; Mroczek D; Serper M; Ladner D; Wolf M
    Prog Transplant; 2022 Sep; 32(3):226-232. PubMed ID: 35686344
    [No Abstract]   [Full Text] [Related]  

  • 15. Corticosteroids as graft-versus-host disease prophylaxis for allogeneic hematopoietic cell transplant recipients with calcineurin inhibitor intolerance.
    Puckrin R; Kwan ACF; Blosser N; Leyshon C; Duggan P; Daly A; Zepeda V; Stewart D; Chaudhry A; Storek J; Jamani K
    Cytotherapy; 2023 Oct; 25(10):1101-1106. PubMed ID: 37306643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Adherence to Immunosuppressants Is Associated With Symptom Experience Among Kidney Transplant Recipients.
    Lee SY; Chu SH; Oh EG; Huh KH
    Transplant Proc; 2015 Nov; 47(9):2707-11. PubMed ID: 26680077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing medication adherence in solid-organ transplant recipients.
    Su GC; Greanya ED; Partovi N; Yoshida EM; Shapiro RJ; Levy RD
    Exp Clin Transplant; 2013 Dec; 11(6):475-81. PubMed ID: 24344939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression, Immunosuppressant Levels, and Clinical Outcomes in Postlung Transplant Recipients.
    Chu MC; Smith PJ; Reynolds JM; Palmer SM; Snyder LD; Gray AL; Blumenthal JA
    Int J Psychiatry Med; 2020 Nov; 55(6):421-436. PubMed ID: 32052665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenges of using medication event monitoring technology with pediatric transplant patients.
    Shellmer DA; Zelikovsky N
    Pediatr Transplant; 2007 Jun; 11(4):422-8. PubMed ID: 17493224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving medication adherence monitoring and clinical outcomes through mHealth: A randomized controlled trial protocol in pediatric stem cell transplant.
    Ralph JE; Sezgin E; Stanek CJ; Landier W; Pai ALH; Gerhardt CA; Skeens MA
    PLoS One; 2023; 18(8):e0289987. PubMed ID: 37590237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.